The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse

Diabetes

Volumn 47, Issue 2, 1998, Pages 186-191

  Sobel, Douglas O ^a,c   Yankelevich, Boris ^b   Goyal, Deepshikha ^a   Nelson, David ^a   Mazumder, Amitabha ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c Division of Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; FEMALE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031914013     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.2.186     Document Type: Article

References (34)

1. Makino S, Kunimoto D, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a nonobese diabetic strain of mice. Exp Anim 29:1-13, 1980
2. Tochino Y, Kanaya T, Makino S: Genetics of NOD mice. In Clinico-Genetic Genesis of Diabetes Mellitus. Mimura G, Baba S, Goto Y, Kobberling J, Eds. Amsterdam, Excerpta Med., 1982, p. 285-291
3. Bottazzo GF, Pujol-Borrell R, Gale E: Etiology of diabetes: the role of autoimmune mechanisms. In Diabetes Annual. Vol. 1. Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier, 1985, p. 52
4. Fujita T, Yui R, Kusumoto Y, Serizawa Y, Makino S, Tochino Y: Lymphocyte insulitis in a nonobese diabetic (NOD) strain of mice: an immunohistochemical and electron microscope investigation. Biochem Res 3:429-443, 1982
5. Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F: Nonobese diabetic mice: immune mechanisms of pancreatic β-cell destruction. Diabetologia 27:113-115, 1985
6. Dobersen MJ: Humoral autoimmune aspects of insulin dependent (type 1) diabetes mellitus. In Concepts in Immunopathology. Vol. 1. Cruse JM, Lewis RE, Eds. Basal, Karger, 1985, p. 47-65
7. Gepts W: Role of cellular immunity in the pathogenesis of type 1 diabetes. In Diabetes and Immunology: Pathogenesis and Immunotherapy. Kolb H, Schernthaner G, Gries FA, Eds. Bern, Huber, 1983. p. 86-99
8. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Maartell R, Rodger NW, Graffenried BV, Wolfe BMJ: Effects of cyclosporine immunosuppression on insulin-dependent diabetes mellitus of recent onset. Science 223:1362-1367, 1984
9. Maruyama T, Takei I, Taniyama M, Kataoka K, Matsuki S: Immunological aspect of nonobese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity. Diabetologia 27:121-123, 1984
10. + T-cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 140:52-58, 1988
11. Miyazaki A, Hanafusa T, Yamada L, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tauri S: Predominance of T-lymphocytes in pancreatic islets and spleen of prediabetic nonobese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol 60:622-630, 1985
12. Ogawa M, Maruyama T, Hasegawa T, Kanaya T, Kobayashi F, Tochino Y, Uda H: The inhibitory effect of neonatal thymectomy on the incidence of insulitis in nonobese diabetes (NOD) mice. Biomed Res 6:103-105, 1985
13. Hayward AR, Shreiber S: Neonatal injection of CD3 antibody into nonobese diabetic mice reduced the incidence of insulitis and diabetes. J Immunol 143:1555-1559, 1989
14. Koike T, Itoh Y, Ishii T, Ito I, Takabayashi K, Maruyama M, Tomioka H, Yoshida S: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36:539-641, 1987
15. Serreze DV, Leiter EH: Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immunol 140:3801-3807, 1988
16. Kai N, Motojima K, Tsunoda T, Kanematsu T: Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. Transplantation 55:936-940, 1993
17. Bougneres PF, Carel JC, Castano L, Boitard C, Gardin JP, Landais P, Hors J, Mihatsch MJ, Paillard M, Chaussain JL, Bach JF: Factors associated with early remission of type 1 diabetes in children treated with cyclosporin. N Engl J Med 318:663-670, 1988
18. Holmgren J: Actions of cholera toxin and the prevention and treatment of cholera Nature 292:413-417, 1981
19. Lai C-Y: The chemistry and biology of cholera toxin CRC. Crit Rev Biochem 9:171-206, 1980
20. m1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside antiserum and cholera toxin. Acta Neuropathol 172:55-61, 1986
21. Woogen SD, Ealding W, Elson CO: Inhibition of murine lymphocyte proliferation by the B-subunit of cholera toxin. J Immunol 139:3764-3770, 1987
22. Holmgren J, Lindholm L, Connroth I: Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. J Exp Med 139:801-819, 1974
23. Yankelevich B, Brown E, Mazumder A: Prevention of induction of acute GVHD by treatment with a novel immunosuppressant: cholera toxin B-subunit. J Immunol 154:3611-3617, 1995
24. Yankelevich B, Brown E, Mazumder A: Induction of donor-specific tolerance to allogeneic bone marrow by a novel immunosuppressant B-subunit of cholera toxin (Abstract). Blood 80 (Suppl. 1):275A, 1992
25. Wicker LS, Miller BJ, Mullen Y: Transfer of autoimmune diabetes mellitus with splenocytes from NOD mice Diabetes 35:855-860, 1986
26. + T-cells by the B-subunit of cholera toxin. Cell Immunol 168:229-234, 1996
27. + T-cell line. Diabetologia 36:716-721, 1993
28. Pankewycz O, Strom TB, Rubin-Kelley VE: Islet-infiltrating T-cell clones from nonobese diabetic mice that promote or prevent accelerated onset diabetes mellitus. Euro J Immunol 21:873-679, 1991
29. Qin H-Y, Sadelain MWJ, Hitchon C, Lauzon J, Singh S: Complete Freund's adjuvant-induced T-cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol 150:2072-2080, 1993
30. Yagi H, Matsumoto M, Kishimoto Y, Makino S, Harada M: Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mice. II. Suppression of the pathogenesis by macrophage transfer from BCG vaccinated mice. Cell Immunol 138:142-149, 1991
31. Sadelain MWJ, Qin H-Y, Lauzon J, Singh B: Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583-589, 1990
32. Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL: Defective thymic T-cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: evidence for thymic T-cell anergy that correlates with the onset of insulitis. J Immunol 146:3763-3771, 1991
33. Holmgren J, Lindholm L, Lonnroth I: Interactions of cholera toxin and toxin derivatives with lymphocytes. J Exp Med 139:801-819, 1974
34. Bergelson LD: Serum gangliosides as endogenous inununomodulators. Immunol Today 16:483-486, 1996